Potent antiviral activity of an antisense oligonucleotide complementary to the intron-exon boundary of human cytomegalovirus genes UL36 and UL37
- 1 May 1995
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 39 (5) , 1157-1161
- https://doi.org/10.1128/aac.39.5.1157
Abstract
An antisense phosphorothioate oligonucleotide complementary to the intron-exon boundary of human cytomegalovirus genes UL36 and UL37 (UL36ANTI) reduced the yield of infectious virus by 99% and inhibited human cytomegalovirus DNA replication at a concentration of 0.08 microM. In addition, oligonucleotides with base substitutions which resulted in base pair mismatches showed lesser degrees of activity, indicating a sequence-specific antisense mechanism. UL36ANTI was also shown to inhibit DNA replication of ganciclovir-resistant strains and human cytomegalovirus clinical isolates.Keywords
This publication has 16 references indexed in Scilit:
- Synergistic antiviral activities of oligonucleoside methylphosphonates complementary to herpes simplex virus type 1 immediate-early mRNAs 4, 5, and 1Antimicrobial Agents and Chemotherapy, 1994
- Antiviral activity of a phosphorothioate oligonucleotide complementary to RNA of the human cytomegalovirus major immediate-early regionAntimicrobial Agents and Chemotherapy, 1993
- Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovirAntimicrobial Agents and Chemotherapy, 1991
- Expression of the human cytomegalovirus UL36–38 immediate early region during permissive infectionVirology, 1991
- Inhibition of herpes simplex virus type 2 growth by phosphorothioate oligodeoxynucleotidesAntimicrobial Agents and Chemotherapy, 1990
- Analysis of the Protein-Coding Content of the Sequence of Human Cytomegalovirus Strain AD169Published by Springer Nature ,1990
- Progressive Disease Due to Ganciclovir-Resistant Cytomegalovirus in Immunocompromised PatientsNew England Journal of Medicine, 1989
- Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus.Proceedings of the National Academy of Sciences, 1988
- Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus.Proceedings of the National Academy of Sciences, 1987
- Rapid colorimetric assay for cell growth and survivalJournal of Immunological Methods, 1986